Skip to content
10-Q

Quarterly Report

CHINA BCT PHARMACY GROUP, INC.

0001213900-13-002766

← back to feed
Filed
May 20, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · May 7, 2013 38.15M sh
Capex Q1 2013 · Mar 31, 2013 $1.55M
Capex Q1 2013 · Mar 31, 2012 $1.05M
Operating Cash Flow Q1 2013 · Mar 31, 2013 $2.66M
Operating Cash Flow restated Q1 2013 · Mar 31, 2012 $1.55M
Long Term Debt Q1 2013 · Mar 31, 2013 $181.62K
Long Term Debt Q1 2013 · Dec 31, 2012 $202.06K
Short Term Debt Q1 2013 · Mar 31, 2013 $15.95M
Short Term Debt Q1 2013 · Dec 31, 2012 $15.86M
Cash And Equivalents Q1 2013 · Mar 31, 2013 $22.8M
Cash And Equivalents Q1 2013 · Dec 31, 2012 $21.61M
Cash And Equivalents Q1 2013 · Mar 31, 2012 $31.59M
Cash And Equivalents Q1 2013 · Dec 31, 2011 $31.48M
Stockholders Equity Q1 2013 · Mar 31, 2013 $138.61M
Stockholders Equity Q1 2013 · Dec 31, 2012 $134.27M
Current Liabilities Q1 2013 · Mar 31, 2013 $85.26M
Current Liabilities Q1 2013 · Dec 31, 2012 $73.48M
Total Liabilities Q1 2013 · Mar 31, 2013 $85.51M
Total Liabilities Q1 2013 · Dec 31, 2012 $73.76M
Current Assets Q1 2013 · Mar 31, 2013 $216.3M
Current Assets Q1 2013 · Dec 31, 2012 $199.52M
Total Assets Q1 2013 · Mar 31, 2013 $262.42M
Total Assets Q1 2013 · Dec 31, 2012 $244.97M
Sga Expense Q1 2013 · Mar 31, 2013 $2.83M
Sga Expense Q1 2013 · Mar 31, 2012 $2M
Net Income Q1 2013 · Mar 31, 2013 $4.59M
Net Income Q1 2013 · Mar 31, 2012 $8.91M
Operating Income Q1 2013 · Mar 31, 2013 $6.02M
Operating Income Q1 2013 · Mar 31, 2012 $12.13M
Gross Profit Q1 2013 · Mar 31, 2013 $11.25M
Gross Profit Q1 2013 · Mar 31, 2012 $16.51M
Cost Of Revenue Q1 2013 · Mar 31, 2013 $55.33M
Cost Of Revenue Q1 2013 · Mar 31, 2012 $54.73M
Revenue Q1 2013 · Mar 31, 2013 $66.58M
Revenue Q1 2013 · Mar 31, 2012 $71.25M